Literature DB >> 12208416

Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study).

Annapoorna S Kini1, Merwin Richard, Javed Suleman, Nohelia Perez, Paul Lee, Edward A Fisher, Mazullah Kamran, Jonathan D Marmur, Samin K Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12208416     DOI： 10.1016/s0002-9149(02)02528-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

Review 1.  Comparative pharmacology of GP IIb/IIIa antagonists.

Authors:  Karsten Schrör; Artur-Aron Weber
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

2.  What is the incidence of myocardial necrosis in elective patients discharged on the same day following percutaneous coronary intervention?

Authors:  I Porto; D J Blackman; D Nicolson; G Niccoli; F Z Kahn; O Ormerod; C Forfar; K Channon; A P Banning
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

3.  Intracoronary abciximab in STEMI using local drug delivery catheter - single center experience.

Authors:  G Sengottuvelu; V Ravi Sekar
Journal:  Indian Heart J       Date:  2013-04-12

4.  Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention.

Authors:  Marino Labinaz; Chuong Ho; Srabani Banerjee; Janet Martin; Stella Chen; Shaila Mensinkai
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.